Emergent BioSolutions
EBS
#6745
Rank
HK$5.00 B
Marketcap
HK$93.81
Share price
3.88%
Change (1 day)
27.79%
Change (1 year)

Emergent BioSolutions (EBS) - Net assets

Net assets on the balance sheet as of September 2025 : HK$4.53 Billion

According to Emergent BioSolutions 's latest financial reports the company has HK$4.53 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Emergent BioSolutions - Net assets on balance sheet (from 2004 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$3.74 B-26.09%
2023-12-31$HK$5.07 B-53.23%
2022-12-31$HK$10.84 B-13.71%
2021-12-31$HK$12.56 B12.02%
2020-12-31$HK$11.21 B32.32%
2019-12-31$HK$8.47 B7.09%
2018-12-31$HK$7.91 B11.06%
2017-12-31$HK$7.12 B54.17%
2016-12-31$HK$4.62 B-9.62%
2015-12-31$HK$5.11 B19.22%
2014-12-31$HK$4.29 B13.12%
2013-12-31$HK$3.79 B10.68%
2012-12-31$HK$3.42 B5.88%
2011-12-31$HK$3.23 B11.34%
2010-12-31$HK$2.90 B53.78%
2009-12-31$HK$1.89 B22.72%
2008-12-31$HK$1.54 B15.43%
2007-12-31$HK$1.33 B23.92%
2006-12-31$HK$1.07 B132.53%
2005-12-31$HK$0.46 B159.7%
2004-12-31$HK$0.17 B
2002-12-31$HK$32.4 M-112.87%
2001-12-31$-HK$0.26 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Merck
MRK
HK$404.08 B 8,811.07%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
HK$1.58 B-65.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$164.84 B 3,535.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
HK$4.65 B 2.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$724.72 B 15,882.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$56.47 B 1,145.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
HK$59.14 M-98.70%๐Ÿ‡บ๐Ÿ‡ธ USA